Cencora to Acquire EyeSouth Partners' Retina Business for $1.1 Billion
Cencora agreed to acquire EyeSouth Partners’ retina business for $1.1 billion, integrating its affiliated physicians into Retina Consultants of America’s management services network. The transaction is expected to be slightly accretive to adjusted diluted EPS within twelve months, pending customary closing conditions and regulatory approvals.
1. Deal Overview
Cencora signed a definitive agreement to purchase EyeSouth Partners’ retina business for $1.1 billion, bringing the affiliated retina physicians into its Retina Consultants of America (RCA) platform. The acquisition enhances RCA’s footprint by adding a strong regional network of retina specialists.
2. Strategic Rationale
By integrating EyeSouth’s physicians, Cencora aims to leverage RCA’s management services model to deliver world-class retina care and expand access to innovative treatments and clinical trials. The deal supports Cencora’s goal of empowering community ophthalmologists with business expertise and shared best practices.
3. Financial Impact
Cencora expects the acquisition to be slightly accretive to adjusted diluted EPS in the first twelve months after closing, net of financing costs. The company’s existing fiscal 2026 guidance does not assume completion of this transaction.
4. Closing Conditions
The transaction remains subject to customary closing conditions, including obtaining required regulatory approvals. Completion timelines will be determined once all conditions are satisfied.